Gut and oral microbiota in autoimmune liver disease

被引：18
|
作者：
Abe, Kazumichi [1 ]
Fujita, Masashi [1 ]
Hayashi, Manabu [1 ]
Okai, Ken [1 ]
Takahashi, Atsushi [1 ]
Ohira, Hiromasa [1 ]
机构：
[1] Fukushima Med Univ, Dept Gastroenterol, Sch Med, Fukushima, Japan
来源：
FUKUSHIMA JOURNAL OF MEDICAL SCIENCE | 2019年 / 65卷 / 03期
关键词：
gut microbiota; oral microbiota; autoimmune hepatitis; primary biliary cholangitis; SALIVARY MICROBIOTA; MEDICAL PROGRESS; ASSOCIATION; BACTERIA;
D O I：
10.5387/fms.2019-21
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The gut microbiota plays a key role in the development of chronic inflammatory liver disease. The gut-liver axis involves inflammatory cells, cytokines, and other molecules that cause liver deterioration. Dysbiosis is important in understanding several liver diseases, especially in relation to the development of autoimmune liver disease. The aim of this review is to provide a current overview of alterations in the gut and oral microbiota associated with autoimmune liver diseases.
引用
收藏
页码：71 / 75
页数：5
相关论文
共 50 条
  • [31] The Gut Microbiota, Tumorigenesis, and Liver Diseases
    Lv, Guishuai
    Cheng, Ningtao
    Wang, Hongyang
    ENGINEERING, 2017, 3 (01) : 110 - 114
  • [32] Impaired central tolerance induces changes in the gut microbiota that exacerbate autoimmune hepatitis
    Centa, Monica
    Weinstein, Erica G. G.
    Clemente, Jose C. C.
    Faith, Jeremiah J. J.
    Fiel, M. Isabel
    Lyallpuri, Robby
    Herbin, Olivier
    Alexandropoulos, Konstantina
    JOURNAL OF AUTOIMMUNITY, 2022, 128
  • [33] Nurturing by nutrition: On the future of gut microbiota management strategies for autoimmune disease
    Larsen, Olaf F. A.
    FRONTIERS IN NUTRITION, 2023, 9
  • [34] Gut Microbiota and Neuroinflammation in Acute Liver Failure and Chronic Liver Disease
    Giuli, Lucia
    Maestri, Marta
    Santopaolo, Francesco
    Pompili, Maurizio
    Ponziani, Francesca Romana
    METABOLITES, 2023, 13 (06)
  • [35] Gut-liver axis: The impact of gut microbiota on non alcoholic fatty liver disease
    Compare, D.
    Coccoli, P.
    Rocco, A.
    Nardone, O. M.
    De Maria, S.
    Carteni, M.
    Nardone, G.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2012, 22 (06) : 471 - 476
  • [36] The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage
    Plaza-Diaz, Julio
    Solis-Urra, Patricio
    Rodriguez-Rodriguez, Fernando
    Olivares-Arancibia, Jorge
    Navarro-Oliveros, Miguel
    Abadia-Molina, Francisco
    Alvarez-Mercado, Ana, I
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 22
  • [37] Recent advances in gut microbiota and thyroid disease: pathogenesis and therapeutics in autoimmune, neoplastic, and nodular conditions
    Fang, Lihua
    Ning, Jie
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [38] The gut microbiota and its role in the development of cardiovascular disease
    Escobar, Carlos
    Aldeguer, Xavier
    Vivas, David
    Fernandez, Sergio Manzano
    Caballero, Eva Gonzalez
    Martin, Ana Garcia
    Barrios, Vivencio
    Freixa-Pamias, Roman
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2025, 23 (1-2) : 23 - 34
  • [39] The association between oral and gut microbiota in male patients with alcohol dependence
    Hu, Lingming
    Ni, Zhaojun
    Zhao, Kangqing
    Li, Xiangxue
    Gao, Xuejiao
    Kang, Yulin
    Yu, Zhoulong
    Qin, Ying
    Zhao, Jingwen
    Peng, Wenjuan
    Lu, Lin
    Sun, Hongqiang
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [40] The interactions between oral-gut axis microbiota and Helicobacter pylori
    Chen, Xi
    Wang, Nanxi
    Wang, Jiannan
    Liao, Binyou
    Cheng, Lei
    Ren, Biao
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
12345